Clavipectoral Block Versus Interscalene Block for Postoperative Analgesia in Midshaft Clavicular Surgery
Ultrasound-guided Clavipectoral Fascia Plane Block Versus Interscalene Brachial Plexus Block for Postoperative Analgesia in Midshaft Clavicular Surgery
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of this study is to compare between (ISBPB) and (CPB) as postoperative analgesic technique following midshaft clavicular fracture open reduction and internal fixation surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 14, 2025
CompletedFirst Posted
Study publicly available on registry
April 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedApril 22, 2026
January 1, 2025
1 year
February 14, 2025
April 18, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Time to first rescue analgesia
The time to first rescue analgesia with time frame of 24 hours after the study block will be recorded.
24 hours after injection
Rescue analgesia consumed
The total dose of rescue analgesia consumed within 24 hours after the block will be recorded.
24 hours after injection
Secondary Outcomes (6)
Incidence of hemi-diaphragmatic paralysis
3 hours after block or 1 hour after recovery from anesthesia.
Visual analogue scale (VAS)
24 hours after injection
Heart rate
24 hours after injection
Mean arterial blood pressure
24 hours after injection.
Motor function of the relevant upper limb
3 hours after block or 1 hour after recovery from anesthesia.
- +1 more secondary outcomes
Study Arms (2)
Interscalene brachial plexus block group
ACTIVE COMPARATORPeripheral nerve block Under sterile conditions, the high frequency probe will be positioned at the level of cricoid cartilage to visualize the brachial plexus between the anterior and middle scalene muscles. A total of 20 ml of local anesthetic (10 ml of bupivacaine 0.5% and 10 ml of normal saline) will be injected after negative aspiration, and needle will be adjusted to achieve its spread between the C5 and C6 nerve roots and between C6 and C7 nerve roots.
Clavipectoral fascia plane block
ACTIVE COMPARATORPeripheral nerve block Under sterile conditions, a high frequency linear probe will be initially placed over the anterior surface of the clavicle in a sagittal orientation. Essentially, there will be one injection on each side of the fracture after negative aspiration. The first injection will be 4-5 cm from the acromial end of the clavicle and the second one will be 4-5 cm from the sternal end of the clavicle. An in-plane technique will be used to view the needle advancing in a caudad to cephalad direction until it will rest on the clavipectoral fascia. The total amount of local anesthetic (LA) mixture will be 20 ml (10 ml of bupivacaine 0.5% and 10 ml of normal saline), divided into 10 ml medially and 10 ml laterally.
Interventions
Ultrasound-guided peripheral nerve block that includes injection of local anesthetics between the C5 and C6 nerve roots and between C6 and C7 nerve roots.
Ultrasound-guided peripheral nerve block that includes injection of local anesthetics between the periosteum of clavicle and the surrounding clavipectoral fascia.
Eligibility Criteria
You may qualify if:
- Patients aged from 21 to 60 years.
- American Society of Anesthesiologists (ASA) class I and II status.
- Of both sexes.
- Patients undergoing elective midshaft clavicle fracture open reduction and internal fixation surgery.
You may not qualify if:
- Patient refusal.
- American Society of Anesthesiologists (ASA) class llI and IV status.
- Patients with bleeding disorders.
- A history of relevant drug allergy to any of the used drugs.
- Alcohol or drug abuse and opioid dependence.
- Pregnant female patients.
- Patients with BMI above 30 kg/m2.
- Patients with infection at site of the fracture or the block procedure.
- Patients with reduced pulmonary functions due to chronic obstructive pulmonary disease (COPD), uncontrolled asthma, pneumothorax or pleural effusion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University
Cairo, Cairo Governorate, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Moustafa K Reyad, Professor
Ain Shams University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2025
First Posted
April 9, 2025
Study Start
January 1, 2025
Primary Completion
January 1, 2026
Study Completion
February 1, 2026
Last Updated
April 22, 2026
Record last verified: 2025-01